Kindstar Globalgene Statements
99
Kindstar Globalgene Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
492.76
100
248.84
50.5
243.92
49.5
52.784
10.7
208.84
42.4
193.97
39.4
49.949
10.1
-3.249
-0.7
—
0
46.7
9.5
3.212
0.7
43.982
8.9
0.045
968.45
727.11
100
422.71
58.1
304.4
41.9
56.466
7.8
236.65
32.5
291.71
40.1
12.691
1.7
-2.106
-0.3
—
0
10.585
1.5
-3.67
-0.5
12.921
1.8
0.02
650.55
659.48
100
360.83
54.7
298.66
45.3
44.76
6.8
204.31
31
225.51
34.2
73.142
11.1
-0.411
-0.06
—
0
72.731
11
9.502
1.4
62.536
9.5
0.062
1 011.94
492.47
100
240.46
48.8
252.02
51.2
47.965
9.7
187.34
38
197.33
40.1
54.689
11.1
-0.687
-0.1
—
0
44.759
9.1
-0.364
-0.07
47.272
9.6
0.552
85.592
438.2
100
204.45
46.7
233.75
53.3
42.36
9.7
164.41
37.5
1 710.55
390.4
-1 476.8
-337.02
-1.121
-0.3
—
0
-1 498.75
-342.02
0.61
0.1
-1 501.7
-342.7
-1.658
905.62